Stefanie Urlinger

Title: Stefanie Urlinger: Innovator in Transcriptional Regulatory Proteins

Introduction

Stefanie Urlinger is a prominent inventor based in Nuremberg, Germany. She has made significant contributions to the field of molecular biology, particularly in the development of transcriptional regulatory proteins. Her innovative work has led to the filing of a patent that showcases her expertise and creativity in this specialized area.

Latest Patents

Stefanie Urlinger holds a patent for "Tet repressor-based transcriptional regulatory proteins." This invention provides a panel of transcriptional activator fusion proteins that include both tetracycline-controlled transactivator proteins and reverse tetracycline transactivator proteins. These transactivators exhibit novel phenotypes, such as altered basal transcriptional activity in the absence of doxycycline and differential induction by tetracycline and its analogs. This patent highlights her ability to push the boundaries of current scientific understanding.

Career Highlights

Throughout her career, Stefanie has demonstrated a commitment to advancing the field of biotechnology. Her work at Tet Systems Holding GmbH & Co. KG has positioned her as a key player in the development of innovative solutions in transcriptional regulation. With a focus on practical applications, her inventions have the potential to impact various areas of research and development.

Collaborations

Stefanie has collaborated with notable scientists in her field, including Wolfgang Hillen and Hermann Bujard. These partnerships have allowed her to enhance her research and contribute to groundbreaking advancements in molecular biology.

Conclusion

Stefanie Urlinger is a trailblazer in the realm of transcriptional regulatory proteins, with a patent that underscores her innovative spirit. Her contributions to biotechnology continue to inspire and pave the way for future discoveries.